 |
L-ornithine phenylacetate |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatic encephalopathy |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-07 00:00:00 |
| Sponsor | Ocera Therapeutics, Inc.;5001 South Miami Blvd, Suite 300;Durham, North Carolina, 27703 |
| |
L-ornithine phenylacetate |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatic encephalopathy |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-07 00:00:00 |
| Sponsor | Ocera Therapeutics, Inc.;5001 South Miami Blvd, Suite 300;Durham, North Carolina, 27703 |